. . . . . . . . . . . . "[The CYP1A1*2B allele may predispose to the development of these sub-groups of AML by augmented phase 1 metabolism to highly reactive intermediates of CYP1A1 substrates including polycyclic aromatic hydrocarbons or by generation of oxidative stress as a metabolic by-product.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2013-07-06"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:32:30+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .